Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000080

President and CEO sold 18,333 shares at an average $51.41 ($942,477)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-02 Sale : show line 1 in the form −8,543 $50.80 $433,984 2,183,866 I
2021-08-02 Sale : show line 2 in the form −9,790 $51.94 $508,493 2,174,076 I
Open-market sales · 18,333 sh · avg $51.41 · $942,477
Loading xslF345X03/wf-form4_162811883181212.xml…